Kara L. Roden
FDA investigator
Appears on 2 documents from 2008 to 2009, mostly at sites in Missouri. Most often cites production record review (21 CFR 211.192).
- 2
- Documents on file
- 18.0
- Observations per 483
- 2008
- First seen
- 2009
- Most recent
What they cite most
From 36 observations- 21 CFR 211.192Production record review5
- 21 CFR 211.194Laboratory records5
- 21 CFR 211.67Equipment cleaning and maintenance4
- 21 CFR 211.160General requirements3
- 21 CFR 211.198Complaint files2
- 21 CFR 314.81Other postmarketing reports2
Activity by year
2008: 1, 2009: 1
Where
Missouri 2
Often inspects with
Is Kara L. Roden coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2009-02-02 | 483 KV PharmaceuticalFeb 2, 2009 · Saint Louis, Missouri | Saint Louis, Missouri | 32 | |
| 2008-06-13 | 483 Meridian Medical Technologies, LLCJun 13, 2008 · St. Louis, Missouri | St. Louis, Missouri | 4 |
About this profile
What does Kara L. Roden inspect?
Kara L. Roden appears on 2 documents on file covering 2 sites, mostly in Missouri.
What do they cite most often?
21 CFR 211.192 (production record review), followed by 21 CFR 211.194 and 21 CFR 211.67.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Kara L. Roden is dated Feb 2, 2009.